SEC Form 4 · accession 0001104659-15-018836
AGILE THERAPEUTICS INC · AGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alfred Altomari
Officer — Chief Executive Officer · Director
Period of report
Mar 11, 2015
Accepted (ET)
Mar 11, 2015 · 3:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001261249
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 11, 2015 | M | 17,500 | $1.76 | A | 75,754 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.76 | Mar 11, 2015 | M | 17,500 | D | — | Dec 9, 2020 | Common Stock | 17,500 | 174,599 | D |
Explanation of responses
- F1This option was granted on December 9, 2010 and is currently fully vested and exercisable.